| Literature DB >> 33920171 |
Jin Yang Baek1, Sun Ju Kim2, Juyoun Shin3, Yeun-Jun Chung3,4, Cheol-In Kang5, Doo Ryeon Chung1,5, Jae-Hoon Song1, Kwan Soo Ko1,2.
Abstract
Since the introduction of the pneumococcal conjugate vaccine, an increase in the incidence of Streptococcus pneumoniae serotype 19A and sequence type 320 (19A-ST320) isolates have been observed worldwide including in South Korea. We conducted a genome-wide analysis to investigate the temporal genetic changes in 26 penicillin-non-susceptible 19A-ST320 pneumococcal isolates from a hospital in South Korea over a period of 17 years (1999; 2004 to 2015). Although the strains were isolated from a single hospital and showed the same genotype and serotype, a whole-genome sequencing (WGS) analysis revealed that the S. pneumoniae isolates showed more extensive genetic variations compared with a reference isolate obtained in 1999. A phylogenetic analysis based on single nucleotide polymorphisms (SNPs) showed that the pneumococcal isolates from South Korea were not grouped together into limited clusters among the 19A-ST320 isolates from several continents. It was predicted that recombination events occurred in 11 isolates; larger numbers of SNPs were found within recombination blocks compared with point mutations identified in five isolates. WGS data indicated that S. pneumoniae 19A-ST320 isolates might have been introduced into South Korea from various other countries. In addition, it was revealed that recombination may play a great role in the evolution of pneumococci even in very limited places and periods.Entities:
Keywords: ST320; pneumococci; recombination; serotype 19A; whole-genome sequencing
Year: 2021 PMID: 33920171 PMCID: PMC8069037 DOI: 10.3390/microorganisms9040795
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Characteristics of the S. pneumoniae isolates analyzed in this study.
| Isolate No. | Isolation Year | Specimen | MIC (mg/L) a | No of | No of INDELs b | Putative Recombination Events | r/m c | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PEN | CRO | LEV | MFX | GFX | |||||||
| 99-176 | 1999 | Sputum | 2 | 1 | 1 | 0.12 | <0.03 | - | - | - | - |
| 99-192 | 1999 | Sputum | 4 | 1 | 1 | 0.12 | <0.03 | 7 | 1 | 0 | 0 |
| 04-041 | 2004 | Nasopharynx | 2 | 2 | 1 | 0.12 | <0.03 | 34 | 6 | 0 | 0 |
| 04-177 | 2004 | Blood | 4 | 1 | 1 | 0.12 | <0.03 | 53 | 11 | 1 | 0.86 |
| 05-384 | 2005 | Sputum | 4 | 2 | 1 | 0.12 | <0.03 | 615 | 17 | 4 | 25.56 |
| 05-404 | 2005 | Tracheal aspirate | 8 | 8 | 1 | 0.12 | <0.03 | 44 | 7 | 0 | 0 |
| 06-101 | 2006 | Sputum | 4 | 1 | 1 | 0.12 | <0.03 | 37 | 7 | 0 | 0 |
| 06-300 | 2006 | Sputum | 2 | 2 | 1 | 0.12 | <0.03 | 101 | 3 | 0 | 0 |
| 07-028 | 2007 | Sputum | 4 | 1 | 1 | 0.12 | <0.03 | 190 | 11 | 0 | 0 |
| 07-093 | 2007 | Pus | 4 | 4 | 0.5 | 0.06 | <0.03 | 2764 | 26 | 11 | 58.33 |
| 08-087 | 2008 | Ear | 4 | 1 | 1 | 0.12 | <0.03 | 44 | 5 | 0 | 0 |
| 08-114 | 2008 | Sputum | 4 | 2 | 1 | 0.12 | <0.03 | 54 | 10 | 0 | 0 |
| 09-125 | 2009 | Nasopharynx | 4 | 2 | 1 | 0.12 | <0.03 | 479 | 13 | 11 | 12.98 |
| 09-145 | 2009 | Sputum | 2 | 1 | 1 | 0.12 | <0.03 | 44 | 8 | 0 | 0 |
| 10-058 | 2010 | Sputum | 4 | 2 | 1 | 0.12 | <0.03 | 51 | 10 | 0 | 0 |
| 10-287 | 2010 | Sputum | 4 | 2 | 1 | 0.12 | <0.03 | 42 | 5 | 0 | 0 |
| 11-138 | 2011 | Nasopharynx | 4 | 1 | 1 | 0.12 | <0.03 | 76 | 9 | 1 | 0.43 |
| 11-194 | 2011 | Tracheal aspirate | 4 | 1 | 0.5 | 0.06 | <0.03 | 748 | 23 | 3 | 37.50 |
| 12-039 | 2012 | Blood | 4 | 2 | 0.5 | 0.12 | <0.03 | 78 | 9 | 2 | 0.30 |
| 12-102 | 2012 | Ear | 4 | 2 | 1 | 0.12 | <0.03 | 67 | 7 | 0 | 0 |
| 13-075 | 2013 | Pleural fluid | 2 | 1 | 1 | 0.12 | <0.03 | 62 | 9 | 0 | 0 |
| 13-103 | 2013 | Blood | 2 | 1 | 1 | 0.12 | <0.03 | 103 | 14 | 2 | 0.43 |
| 14-109 | 2014 | Sputum | 4 | 1 | 1 | 0.12 | <0.03 | 2002 | 49 | 9 | 34.77 |
| 14-212 | 2014 | Sputum | 4 | 1 | 1 | 0.12 | <0.03 | 68 | 14 | 1 | 0.16 |
| 15-123 | 2015 | Others | 2 | 1 | 1 | 0.12 | <0.03 | 86 | 13 | 2 | 0.19 |
| 15-019 | 2015 | Blood | 2 | 1 | 1 | 0.12 | <0.03 | 11,542 | 90 | 1 | ND |
a MIC, minimum inhibitory concentration; PEN, penicillin; CRO, ceftriaxone; LEV, levofloxacin; MFX, moxifloxacin; GFX, gemifloxacin; ND, not determined. b The numbers of single nucleotide polymorphisms (SNPs) and insertion-deletions (INDELs) were measured via a comparison with the nucleotide sequences of isolate 99-176. c r/m, number of SNPs within recombination blocks/number of SNPs outside recombination blocks.
Figure 1Distribution of genes showing sequence variation. The colored blocks indicate the genes showing sequence variations compared with isolate 99-176. It is represented regardless of the length of the genes. The color was marked differently depending on the degree of variation. The genes showing SNP rates ≥ 4% are shown at the top of the figure. The location of the CPS locus is indicated by a blue box. SNP, single nucleotide polymorphism; CPS, capsular polysaccharide.
Figure 2(A) Phylogenetic tree and predicted recombination sites of 179 S. pneumoniae 19A-ST320 isolates based on whole-genome sequence data of 26 isolates determined in this study. Sequences of 151 isolates were retrieved from the Global Pneumococcal Sequencing (GPS) project (https://www.pneumogen.net/gps/) (accessed on 12 February 2021) and sequences of SP61 and SP64 were obtained from Germany. On the left, the phylogenetic tree constructed via RAxML based on SNPs is shown. The isolates from South Korea are represented with a red background. On the right, recombination sites are shown. Red bars indicate that recombination is ancestral, i.e., occurred at a non-terminal nod. Blue bars are shown if they appeared in one isolate. (B) A sub-cluster containing S. pneumoniae isolates 15-075 and 06-300, which are represented with a red background. GPS, global pneumococcal sequencing; RAxML, Randomized Axelerated Maximum Likelihood; SNPs, single nucleotide polymorphisms.
Figure 3Phylogenetic tree and predicted recombination sites of 25 S. pneumoniae 19A-ST320 isolates analyzed in this study. The phylogenetic tree constructed via RAxML based on SNPs is shown on the left. The isolates showing the predicted recombination events are indicated with a colored background; red background indicates that the r/m value was 10 or more; blue background indicates that the r/m value was <1. A horizontal and colored bar showing the predicted recombination events is displayed for each isolate on the right. Recombination blocks predicted in multiple isolates are presented in a red color and those predicted in one isolate are presented in blue. The genes within recombination blocks including multiple genes are shown at the top and bottom of the figure. The location of the CPS locus is indicated by a purple box. RAxML, Randomized Axelerated Maximum Likelihood; SNPs, single nucleotide polymorphisms; CPS, capsular polysaccharide.